Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Table of contents
- Overview
- No-property rule
- The bundle theory of property
- Rights described by bundle theory of property
- Commodification of body material
- John Moore vs. Reagents of University of California
- Damage by loss of biomaterial
- Double character of body material
- Anonymisation and pseudonymisation
- Donor information: specific vs. broad consent
- Conclusions for practice I
- Conclusions for practice II
- Literature
- Concluding remarks
Topics Covered
- No-property rule
- The bundle theory of property
- Commodification of body material
- Damage by loss of biomaterial
- Double character of body material
- Anonymization and pseudonymization of body material and accompanying data
- Donor information: specific vs. broad consent
Talk Citation
Lenk, C. (2016, January 31). The ethical and legal framework for international tissue transfer [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/PXJV2786.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Dr. Christian Lenk has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
The ethical and legal framework for international tissue transfer
Other Talks in the Series: Tissue in Research
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Christian Lenk from
the Institute for the History,
Theory & Ethics of Medicine
at Ulm University in Germany.
And I'm also the Chair
of the Research Ethics Committee
at my university.
And today I will talk to you
about the theme,
The Ethical and Legal Framework
for International
Tissue Transfer.
0:22
On table of contents,
you see that
I will first give you
a short introduction
into the theme,
and then I will go into
some more theoretical issues
for the introduction,
namely the no-property rule,
then the bundle theory
of property,
and the problem
of commodification
of body material.
And then I will go
more to practical
issues of transfer
of human tissue for research,
and then the last points
come to some conclusions
for the practice of
research that are surely
also interesting for you.
1:01
I will then come to
my introduction and first,
it is important to describe
the area of relevance
for my talk and
the handling of tissue
for research has to be
distinguished from other fields.
For example,
tissue and body material
from transplantation purposes
because there you will find
other ethical
and legal regulations.
Many of the notions
which are used in ethics and law
do also have a meaning
in common language,
like for example,
the notion of donation,
or also of commercialization.
In the case of donation,
when you make a donation,
in practice,
normally you will see
that this is implicitly
or explicitly bound
to a specific use
and this is also
the case in the area
of tissue research.
Tissue or body material
is given by the donor
for a noncommercial use
normally in medical research
and on the other side,
it is expected that it is
used for specified
and described aims,
for example,
non-commercial research
at the university hospital.
So you see, on the one hand,
the term of donation
is also used in common language,
we can say,
and on the other hand,
it is in a specified way
used in medical practice
and in research.
And then you have to see,
okay,
what issues
are there important for me
if I talk of tissue donation?
And so we can say obviously
also in medical research,
we have then
the donation as a gift
with a specified use
and the researcher
has then the right to use
the tissue in a specified way.
You can also say about the time
that we have different ethical
and legal qualities
of human tissue.
For example, first,
it is donated from the patient,
the tissue,
but then it might change
its character or its quality.
For example, if it is used
as a medicinal product,
like, for example,
a blood donation.
We can also say
that sometimes there are
different ethical
and legal qualities
of human tissue.
For example, directly
at the donation then tissue
or body material
comes from the patient
and then it is used
in the medical system
for other purposes.
Think of a blood donation,
for example,
if you do something
with this body material
and later on, you can use it,
for example,
as a medicinal product.
Then it is very important to see
that in different countries,
there are also different ethical
and legal regulations.
For example,
in the European area
or in the US area,
and I only want to
give you one example
for such a regulation
and this is the last point,
the recommendation REC
from 2006 number 4
of the Council of Europe,
from the Committee of Ministers
on research
on biological materials
of human origin
and for medical research,
such recommendations
and guidelines
are very important
to see for a larger area,
like here for the
European countries, okay.
What are common rules
for the treatment
and for dealing
with human tissue
and body material,
and this makes it quite easier,
for example,
in the international context,
to have contact with
colleagues in other countries
and to use also body material
from other countries.
And if you take this
recommendation,
for example, then you
have an overview about
the most important points there,
namely the information of patients,
how you should use
body material for research
and also what limitations
there are, for example,
in respect to possible
commercialization
of body material.
The last point
is very important.